H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats

Biochimie

Volumn 131, Issue , 2016, Pages 68-76

  Pandey, Anuradha ^a   Goru, Santosh Kumar ^a   Kadakol, Almesh ^a   Malek, Vajir ^a   Sharma, Nisha ^a   Gaikwad, Anil Bhanudas ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Angiotensin II receptors; Fibrosis; H2A lysine 119 monoubiquitination; Macrophage infiltration; Type 2 diabetic nephropathy

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; HISTONE H2A; HISTONE H3; MONOCYTE CHEMOTACTIC PROTEIN; STREPTOZOCIN; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CCL2 PROTEIN, RAT; HISTONE; IMIDAZOLE DERIVATIVE; LYSINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRIDINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EPIGENETICS; HISTONE ACETYLATION; HISTONE MODIFICATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; MACROPHAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; UBIQUITINATION; ANIMAL; COMPLICATION; DIABETIC NEPHROPATHIES; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BLOTTING, WESTERN; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FIBROSIS; HISTONES; IMIDAZOLES; KIDNEY; LYSINE; MACROPHAGES; MALE; PROMOTER REGIONS, GENETIC; PYRIDINES; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITINATION;

EID: 84988933935     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2016.09.016     Document Type: Article

References (35)

1. [1] Elmarakby, A.A., Sullivan, J.C., Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc. Ther. 30 (2012), 49–59.
2. [2] Soetikno, V., Sari, F.R., Veeraveedu, P.T., Thandavarayan, R.A., Harima, M., Sukumaran, V., Lakshmanan, A.P., Suzuki, K., Kawachi, H., Watanabe, K., Curcumin ameliorates macrophage infiltration by inhibiting NF-kB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutr. Metab. 8 (2011), 1–11.
3. [3] Esteban, V., Lorenzo, O., Rupérez, M., Suzuki, Y., Mezzano, S., Blanco, J., Kretzler, M., Sugaya, T., Egido, J., Ruiz-Ortega, M., Angiotensin II, via AT1 and AT2 receptors and NF-κB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15 (2004), 1514–1529.
4. [4] Ruiz-Ortega, M., Rupérez, M., Esteban, V., Rodriguez-Vita, J., Sanchez-López, E., Egido, J., Modulation of angiotensin II effects, a potential novel approach to inflammatory and immune diseases. Curr. Med. Chem. Anti Inflamm. Anti Allergy Agents 2 (2003), 379–394.
5. [5] Zi, Z., Chapnick, D.A., Liu, X., Dynamics of TGF-β/Smad signaling. FEBS Lett. 586 (2012), 1921–1928.
6. [6] Cremer, T., Cremer, C., Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2 (2001), 292–301.
7. [7] Grunstein, M., Histone acetylation in chromatin structure and transcription. Nature 389 (1997), 349–352.
8. [8] Cheung, W.L., Briggs, S.D., Allis, C.D., Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12 (2000), 326–333.
9. [9] Kouzarides, T., Chromatin modifications and their function. Cell 128 (2007), 693–705.
10. [10] Sterner, D.E., Berger, S.L., Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000), 435–459.
11. [11] Reddy, M.A., Sumanth, P., Lanting, L., Yuan, H., Wang, M., Mar, D., Alpers, C.E., Bomsztyk, K., Natarajan, R., Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int. 85 (2014), 362–373.
12. [12] Sun, G., Reddy, M.A., Yuan, H., Lanting, L., Kato, M., Natarajan, R., Epigenetic histone methylation modulates fibrotic gene expression. J. Am. Soc. Nephrol. 21 (2010), 2069–2080.
13. [13] Yuan, H., Reddy, M.A., Sun, G., Lanting, L., Wang, M., Kato, M., Natarajan, R., Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells. Am. J. Physiol– Ren. Physiol. 304 (2013), F601–F613.
14. [14] Gaikwad, A.B., Sayyed, S.G., Lichtnekert, J., Tikoo, K., Anders, H.-J., Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. Am. J. Pathol. 176 (2010), 1079–1083.
15. [15] Shaid, S., Brandts, C., Serve, H., Dikic, I., Ubiquitination and selective autophagy. Cell Death Differ. 20 (2013), 21–30.
16. [16] Vissers, J., Nicassio, F., van Lohuizen, M., Di Fiore, P.P., Citterio, E., The many faces of ubiquitinated histone H2A: insights from the DUBs. Cell Div., 3, 2008, b17.
17. [17] Gao, C., Chen, G., Liu, L., Li, X., He, J., Jiang, L., Zhu, J., Xu, Y., Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells. J. Diabetes Res. 2013 (2013), 1–7.
18. [18] Huang, W., Xu, L., Zhou, X., Gao, C., Yang, M., Chen, G., Zhu, J., Jiang, L., Gan, H., Gou, F., Feng, H., Peng, J., Xu, Y., High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells. Biochem Biophys. Res. Commun. 438 (2013), 568–574.
19. [19] Pandey, A., Goru, S.K., Kadakol, A., Malek, V., Gaikwad, A.B., Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney. Biochimie 118 (2015), 71–81.
20. [20] Kadakol, A., Malek, V., Goru, S.K., Pandey, A., Gaikwad, A.B., Esculetin reverses histone H2A/H2B ubiquitination, H3 dimethylation, acetylation and phosphorylation in preventing type 2 diabetic cardiomyopathy. J. Funct. Foods 17 (2015), 127–136.
21. [21] Umschweif, G., Liraz-Zaltsman, S., Shabashov, D., Alexandrovich, A., Trembovler, V., Horowitz, M., Shohami, E., Angiotensin receptor type 2 activation induces neuroprotection and Neurogenesis after traumatic brain injury. Neurotherapeutics 11 (2014), 665–678.
22. [22] Kadakol, A., Malek, V., Goru, S.K., Pandey, A., Bagal, S., Gaikwad, A.B., Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochem Biophys. Res. Commun. 461 (2015), 342–347.
23. [23] Goru, S.K., Kadakol, A., Pandey, A., Malek, V., Sharma, N., Gaikwad, A.B., Histone H2AK119 and H2BK120 monoubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes induced renal fibrosis. Biochem. J., 2016, 10.1042/BCJ20160595 article no. BCJ20160595.
24. [24] Parving, H.-H., Persson, F., Lewis, J.B., Lewis, E.J., Hollenberg, N.K., Aliskiren combined with losartan in type 2 diabetes and nephropathy. New Eng. J. Med. 358 (2008), 2433–2446.
25. [25] Kanasaki, K., Taduri, G., Koya, D., Diabetic nephropathy: the role of inflammation in fibroblasts activation and kidney fibrosis. Front. Endocrinol. 4 (2013), 1–15.
26. [26] Chow, F.Y., Nikolic-Paterson, D.J., Atkins, R.C., Tesch, G.H., Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol. Dial. Transpl. 19 (2004), 2987–2996.
27. [27] Chen, J., Guo, Y., Zeng, W., Huang, L., Pang, Q., Nie, L., Mu, J., Yuan, F., Feng, B., ER stress triggers MCP-1 expression through SET7/9-induced histone methylation in the kidneys of db/db mice. Am. J. Physiol. Ren. Physiol. 306 (2014), F916–F925.
28. [28] Paneni, F., Costantino, S., Battista, R., Castello, L., Capretti, G., Chiandotto, S., Scavone, G., Villano, A., Pitocco, D., Lanza, G., Volpe, M., Lüscher, T.F., Cosentino, F., Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes. Circ. Cardiovasc Genet. 8 (2014), 150–158.
29. [29] Sayyed, S.G., Gaikwad, A.B., Lichtnekert, J., Kulkarni, O., Eulberg, D., Klussmann, S., Tikoo, K., Anders, H.-J., Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol. Dial. Transpl. 25 (2010), 11–17.
30. [30] Zhou, W., Zhu, P., Wang, J., Pascual, G., Ohgi, K.A., Lozach, J., Glass, C.K., Rosenfeld, M.G., Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol. Cell 29 (2008), 69–80.
31. [31] Lan, H.Y., Transforming growth factor-β/Smad signalling in diabetic nephropathy. Clin. Exp. Pharmacol. Physiol. 39 (2012), 731–738.
32. [32] Wolf, G., Jocks, T., Zahner, G., Panzer, U., Stahl, R.A.K., Existence of a regulatory loop between MCP-1 and TGF-β in glomerular immune injury. Am. J. Physiol. Ren. Physiol. 283 (2002), F1075–F1084.
33. [33] Sakai, N., Wada, T., Furuichi, K., Shimizu, K., Kokubo, S., Hara, A., Yamahana, J., Okumura, T., Matsushima, K., Yokoyama, H., Kaneko, S., MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J. Leuk. Biol. 79 (2006), 555–563.
34. [34] Paul, S., Dysfunction of the ubiquitin–proteasome system in multiple disease conditions: therapeutic approaches. BioEssays 30 (2008), 1172–1184.
35. [35] Gao, C., Huang, W., Kanasaki, K., Xu, Y., The role of ubiquitination and sumoylation in diabetic nephropathy. Biomed. Res. Int. 2014 (2014), 11–16.